cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.svnmhe
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Acleris lacordairana (Duponchel, 1836)",
 "HasCoordinate is true",
 "Country is Japan",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0211743-220831081235567/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.bech2q
title: Occurrence Download

description: A dataset containing 7602 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Arthropoda, Nematoda, Tardigrada, Rotifera, Annelida, Mollusca, Platyhelminthes)",
 "Geometry POLYGON ((-71.48008 44.194906, -71.468835 43.925055, -71.095393 43.932517, -71.104941 44.202438, -71.48008 44.194906))",
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "Year is greater than or equal to 1900",
 {
 "not" : {
 "CoordinateUncertaintyInMeters" : [
 "is one of (301, 3036, 999, 9999)"
 ]
 }
 },
 {
 "or" : [
 "CoordinateUncertaintyInMeters is less than 10000",
 "CoordinateUncertaintyInMeters is null"
 ]
 }
 ]
}

 The dataset includes 7602 records from 41 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0236025-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/inscriptifact-ouc112037445
title: Cuneiform Tablet 1913.14.1688, Spurlock 1913.14.1688

description: [Text Description:] Administrative tablet ❧ [Text or Publication Number Note:] Spurlock 1913.14.1688; CDLI P421539 ❧ [Medium:] Clay ❧ [Script Note:] Non-Alphabetic Cuneiform ❧ [Physical Object Description:] Brownish Pink (5YR 8/1.5) Yellowish White (10YR 9/1.5) ❧ [Physical Object Note:] 4.5 x 3.4 x 1.8 cm (27 g)
DOI: 10.15468/dl.ykn95v
title: Occurrence Download

description: A dataset containing 805 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Anolis heterodermus Duméril, 1851"
 ]
}

 The dataset includes 805 records from 58 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0258639-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fyg6aa
title: Occurrence Download

description: A dataset containing 7 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Fagopyrum fagopyrum (L.) H.Karst."
 ]
}

 The dataset includes 7 records from 6 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057607-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8tbhvb
title: Occurrence Download

description: A dataset containing 978367 species occurrences available in GBIF matching the query:
{
 "Country" : [
 "is El Salvador"
 ]
}

 The dataset includes 978367 records from 703 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0233266-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/inscriptifact-ouc112036649
title: Cuneiform Tablet 1913.14.1685, Spurlock 1913.14.1685

description: [Text Description:] Administrative tablet ❧ [Text or Publication Number Note:] Spurlock 1913.14.1685; CDLI P421536 ❧ [Medium:] Clay ❧ [Script Note:] Non-Alphabetic Cuneiform ❧ [Physical Object Description:] Yellowish White (10YR 9/1.5) ❧ [Physical Object Note:] 3.2 x 2.2 x 1.6 cm (10 g)
DOI: 10.15468/dl.8bpzkz
title: Occurrence Download

description: A dataset containing 178 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is India",
 "Geometry POLYGON((76.26795 6.64382,80.93097 5.81571,81.24324 10.54368,81.2052 14.68778,82.72278 15.78593,86.39027 18.92387,90.56363 20.70843,94.10466 20.70843,99.02931 29.25438,88.73071 30.46683,85.24889 30.15588,81.28682 32.51425,80.34279 36.64886,75.20351 36.71702,71.65215 34.55531,68.74381 29.70162,66.27896 24.19353,67.3547 20.06641,71.45789 19.86235,71.965 15.6799,73.34809 9.68583,76.26795 6.64382))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Xylocopa fenestrata (Fabricius, 1798)"
 ]
}

 The dataset includes 178 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0227470-220831081235567/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/inscriptifact-ouc112036811
title: Cuneiform Tablet 1913.14.1685, Spurlock 1913.14.1685

description: [Text Description:] Administrative tablet ❧ [Text or Publication Number Note:] Spurlock 1913.14.1685; CDLI P421536 ❧ [Medium:] Clay ❧ [Script Note:] Non-Alphabetic Cuneiform ❧ [Physical Object Description:] Yellowish White (10YR 9/1.5) ❧ [Physical Object Note:] 3.2 x 2.2 x 1.6 cm (10 g)
DOI: 10.15468/dl.8r3u2u
title: Occurrence Download

description: A dataset containing 277 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Sorghum halepense f. muticum (Hack.) C.E.Hubb."
 ]
}

 The dataset includes 277 records from 26 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057629-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.etaeb8
title: Occurrence Download

description: A dataset containing 218 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ischnosiphon cannoideus L.Andersson"
 ]
}

 The dataset includes 218 records from 27 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0255090-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.weudn7
title: Occurrence Download

description: A dataset containing 11 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sigara matsumurai Jaczewski, 1968",
 "HasCoordinate is true",
 "Country is Japan",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 11 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0211734-220831081235567/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/inscriptifact-ouc112036728
title: Cuneiform Tablet 1913.14.1685, Spurlock 1913.14.1685

description: [Text Description:] Administrative tablet ❧ [Text or Publication Number Note:] Spurlock 1913.14.1685; CDLI P421536 ❧ [Medium:] Clay ❧ [Script Note:] Non-Alphabetic Cuneiform ❧ [Physical Object Description:] Yellowish White (10YR 9/1.5) ❧ [Physical Object Note:] 3.2 x 2.2 x 1.6 cm (10 g)
DOI: 10.15468/dl.4zpdz4
title: Occurrence Download

description: A dataset containing 4795 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Brevibacillus",
 "Year 1921-2021"
 ]
}

 The dataset includes 4795 records from 250 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0015065-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jtsq8q
title: Occurrence Download

description: A dataset containing 1845 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Eurytides Hübner, 1821"
 ]
}

 The dataset includes 1845 records from 70 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0095376-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/inscriptifact-ouc112036683
title: Cuneiform Tablet 1913.14.1685, Spurlock 1913.14.1685

description: [Text Description:] Administrative tablet ❧ [Text or Publication Number Note:] Spurlock 1913.14.1685; CDLI P421536 ❧ [Medium:] Clay ❧ [Script Note:] Non-Alphabetic Cuneiform ❧ [Physical Object Description:] Yellowish White (10YR 9/1.5) ❧ [Physical Object Note:] 3.2 x 2.2 x 1.6 cm (10 g)
DOI: 10.15468/dl.tqean9
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sigara distorta (Distant, 1910)",
 "HasCoordinate is true",
 "Country is Japan",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0211737-220831081235567/datasets/export for details.
DOI: 10.15468/dl.bea7jv
title: Occurrence Download

description: A dataset containing 175 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Iris prismatica Pursh)",
 "HasCoordinate is true"
 ]
}

 The dataset includes 175 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0064999-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.59ga7j
title: Occurrence Download

description: A dataset containing 2255 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Hypericum densiflorum Pursh"
 ]
}

 The dataset includes 2255 records from 128 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0250673-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.13145/bacdive163254.20251217.10
title: <i>Aureispira</i> <i>marina</i> Hosoya <i>et al.</i> 2006

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.15468/dl.3gk9wa
title: Occurrence Download

description: A dataset containing 181723 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Terminalia"
 ]
}

 The dataset includes 181723 records from 1190 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0079010-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.13145/bacdive163255.20241212.9.2
title: <i>Aureispira</i> <i>marina</i> Hosoya <i>et al.</i> 2006

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163255.20251217.10
title: <i>Aureispira</i> <i>marina</i> Hosoya <i>et al.</i> 2006

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163256.20241212.9.2
title: <i>Leifsonia</i> <i>lichenia</i> An <i>et al.</i> 2010

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163256.20251217.10
title: <i>Leifsonia</i> <i>lichenia</i> An <i>et al.</i> 2010

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163257.20241212.9.2
title: <i>Aeromonas</i> <i>hydrophila</i> (Chester 1901) Stanier 1943

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163257.20251217.10
title: <i>Aeromonas</i> <i>hydrophila</i> (Chester 1901) Stanier 1943

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163258.20241212.9.2
title: <i>Aeromonas</i> sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163258.20251217.10
title: <i>Aeromonas</i> sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive163259.20241212.9.2
title: <i>Aeromonas</i> <i>punctata</i> (Zimmermann 1890) Snieszko 1957

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.6084/m9.figshare.24893608
title: Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials

description: This review aimed to systematically evaluate the immunogenicity and safety of the candidate Ebola virus vaccine (EVV). We searched five databases for randomized controlled trials (RCTs) evaluating the effects of EVV on healthy adults. The primary outcomes were relative risk (RR) of sero-conversion or sero-response of EVV in healthy adults between the groups that received EVV and the controls. Twenty-nine RCTs (<i>n</i> = 23573) were included. There was a significant difference in RR of sero-conversion of EVV (RR 13.18; 95% CI 11.28–15.41; I<sup>2</sup> = 33%; <i>P</i> &lt; 0.01) between the two groups. There was a significant difference in RR of adverse events (AEs) of EVV (RR 1.49; 95% CI 1.27–1.74; I<sup>2</sup> = 88%; <i>P</i> &lt; 0.01), although no difference in RR of serious AE (SAE) between the two groups. Subgroup analysis showed that there was no significant difference in RR of AEs for DNAEBO, EBOV-GP, MVA, and rVSVN4CT1 vaccines, compared with controls. The DNAEBO, EBOV-GP, MVA, and rVSVN4CT1 vaccines are likely to be safe and immunogenic, tending to support the vaccination against Ebola disease. These findings should provide much-needed evidence for public health policy makers to develop preventive measures based on disease prevalence features and socio-economic conditions.
DOI: 10.6084/m9.figshare.25324523
title: Cost-effectiveness of nonavalent HPV vaccination in the Netherlands

description: A bivalent human papillomavirus vaccine (2vHPV) is currently used in the Netherlands; a nonavalent vaccine (9vHPV) is also licensed. We compared the public health and economic benefits of 2vHPV- and 9vHPV-based vaccination strategies in the Netherlands over 100 years using a validated deterministic dynamic transmission metapopulation model. Compared to 2vHPV, the 9vHPV strategy averted an additional 3,245 cases of and 825 deaths from 9vHPV-strain-attributable cancers, 4,247 cases of and 190 deaths from recurrent respiratory papillomatosis (RRP), and 1,009,637 cases of anogenital warts (AGWs), with an incremental cost-effectiveness ratio (ICER) of €4,975 per quality-adjusted life year (QALY) gained. The ICER increased in a scenario with increased HPV vaccination coverage rates and was relatively robust to one-way deterministic sensitivity analyses, with variation in the disease utility parameter having the most impact. When catch-up vaccination for individuals ≤26 years of age was added to the model, vaccinating with 9vHPV averted additional cancers and AGWs compared to 2vHPV vaccination. Our analyses predict that transitioning from a 2vHPV- to a 9vHPV-based vaccination strategy would be cost-effective in the Netherlands.
DOI: 10.6084/m9.figshare.25324523.v1
title: Cost-effectiveness of nonavalent HPV vaccination in the Netherlands

description: A bivalent human papillomavirus vaccine (2vHPV) is currently used in the Netherlands; a nonavalent vaccine (9vHPV) is also licensed. We compared the public health and economic benefits of 2vHPV- and 9vHPV-based vaccination strategies in the Netherlands over 100 years using a validated deterministic dynamic transmission metapopulation model. Compared to 2vHPV, the 9vHPV strategy averted an additional 3,245 cases of and 825 deaths from 9vHPV-strain-attributable cancers, 4,247 cases of and 190 deaths from recurrent respiratory papillomatosis (RRP), and 1,009,637 cases of anogenital warts (AGWs), with an incremental cost-effectiveness ratio (ICER) of €4,975 per quality-adjusted life year (QALY) gained. The ICER increased in a scenario with increased HPV vaccination coverage rates and was relatively robust to one-way deterministic sensitivity analyses, with variation in the disease utility parameter having the most impact. When catch-up vaccination for individuals ≤26 years of age was added to the model, vaccinating with 9vHPV averted additional cancers and AGWs compared to 2vHPV vaccination. Our analyses predict that transitioning from a 2vHPV- to a 9vHPV-based vaccination strategy would be cost-effective in the Netherlands.
DOI: 10.3535/a38-wqm-wh5
title: Lepidoptera Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.24799686
title: Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses

description: There is a lack of synthesis of literature to determine hepatitis B vaccine (HepB) strategies for hepatitis B virus (HBV) supported by quality evidence. We aimed to explore the efficacy and safety of HepB strategies among people with different characteristics. PubMed, Cochrane Library, Embase, and Web of Science were searched for meta-analyses comparing the efficacy and safety of HepB up to July 2023. Twenty-one meta-analyses comparing 83 associations were included, with 16 high quality, 4 moderate, and 1 low quality assessed by AMSTAR 2. Highly suggestive evidence supports HepB booster and HepB with 1018 adjuvant (HBsAg-1018) for improved seroprotection, and targeted and universal HepB vaccination reduced HBV infection Suggestive evidence indicated that targeted vaccination decreased the rate of hepatitis B surface antibody positivity and booster doses increased seroprotection in people aged 10–20. Weak evidence suggests potential local/systemic reaction risk with nucleotide analogs or HBsAg-1018. Convincing evidence shows HLA-DPB1*04:01 and DPB1*04:02 increased, while DPB1*05:01 decreased, hepatitis B antibody response. Obesity may reduce HepB seroprotection, as highly suggested. Targeted vaccination could effectively reduce HBV infection, and adjuvant and booster vaccinations enhance seroprotection without significant reaction. Factors such as obesity and genetic polymorphisms may affect the efficacy.
DOI: 10.6084/m9.figshare.24893608.v1
title: Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials

description: This review aimed to systematically evaluate the immunogenicity and safety of the candidate Ebola virus vaccine (EVV). We searched five databases for randomized controlled trials (RCTs) evaluating the effects of EVV on healthy adults. The primary outcomes were relative risk (RR) of sero-conversion or sero-response of EVV in healthy adults between the groups that received EVV and the controls. Twenty-nine RCTs (<i>n</i> = 23573) were included. There was a significant difference in RR of sero-conversion of EVV (RR 13.18; 95% CI 11.28–15.41; I<sup>2</sup> = 33%; <i>P</i> &lt; 0.01) between the two groups. There was a significant difference in RR of adverse events (AEs) of EVV (RR 1.49; 95% CI 1.27–1.74; I<sup>2</sup> = 88%; <i>P</i> &lt; 0.01), although no difference in RR of serious AE (SAE) between the two groups. Subgroup analysis showed that there was no significant difference in RR of AEs for DNAEBO, EBOV-GP, MVA, and rVSVN4CT1 vaccines, compared with controls. The DNAEBO, EBOV-GP, MVA, and rVSVN4CT1 vaccines are likely to be safe and immunogenic, tending to support the vaccination against Ebola disease. These findings should provide much-needed evidence for public health policy makers to develop preventive measures based on disease prevalence features and socio-economic conditions.
DOI: 10.3535/a90-xvp-me8
title: Lepidoptera Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/xhk-hvy-r5y
title: Pieris canidia (Sparrman, 1768)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.24799686.v2
title: Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses

description: There is a lack of synthesis of literature to determine hepatitis B vaccine (HepB) strategies for hepatitis B virus (HBV) supported by quality evidence. We aimed to explore the efficacy and safety of HepB strategies among people with different characteristics. PubMed, Cochrane Library, Embase, and Web of Science were searched for meta-analyses comparing the efficacy and safety of HepB up to July 2023. Twenty-one meta-analyses comparing 83 associations were included, with 16 high quality, 4 moderate, and 1 low quality assessed by AMSTAR 2. Highly suggestive evidence supports HepB booster and HepB with 1018 adjuvant (HBsAg-1018) for improved seroprotection, and targeted and universal HepB vaccination reduced HBV infection Suggestive evidence indicated that targeted vaccination decreased the rate of hepatitis B surface antibody positivity and booster doses increased seroprotection in people aged 10–20. Weak evidence suggests potential local/systemic reaction risk with nucleotide analogs or HBsAg-1018. Convincing evidence shows HLA-DPB1*04:01 and DPB1*04:02 increased, while DPB1*05:01 decreased, hepatitis B antibody response. Obesity may reduce HepB seroprotection, as highly suggested. Targeted vaccination could effectively reduce HBV infection, and adjuvant and booster vaccinations enhance seroprotection without significant reaction. Factors such as obesity and genetic polymorphisms may affect the efficacy.